01 36TAKEDA PHARMS USA
01 27700128
02 27785627
03 67807689
04 27959946
05 28071130
06 68173663
07 68288539
08 68637079
09 29101660
10 29320714
01 12Y
02 24Blank
01 24Y
02 12Blank
01 122025-03-15
02 42026-07-31
03 22027-01-22
04 22027-01-30
05 22028-06-08
06 62028-06-27
07 22029-02-03
08 62029-06-04
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2025-03-15
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 8173663
Drug Substance Claim :
Drug Product Claim :
Application Number : 22426
Patent Use Code : U-1338
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2025-03-15
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
Patent Expiration Date : 2028-06-27
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
US Patent Number : 7807689
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22426
Patent Use Code : U-1337
Delist Requested :
Patent Use Description : METHOD OF TREATING DIA...
Patent Expiration Date : 2028-06-27
LOOKING FOR A SUPPLIER?
